## Core Concept
The question tests knowledge of drug-induced lupus erythematosus (DILE), a condition similar to systemic lupus erythematosus (SLE) but caused by certain medications. DILE is characterized by the presence of autoantibodies, particularly antinuclear antibodies (ANA), and clinical manifestations such as arthritis, rash, and serositis. The condition is often associated with drugs that can alter the immune response.

## Why the Correct Answer is Right
Procainamide and hydralazine are well-known to cause drug-induced lupus erythematosus. These medications can lead to the production of autoantibodies, including ANA, and induce clinical symptoms similar to those of SLE. The exact mechanism is not fully understood but is thought to involve the alteration of self-antigens and the activation of autoreactive T cells.

## Why Each Wrong Option is Incorrect
* **Option A:** This option is incorrect because it is not specified, but common drugs known to induce lupus-like features include hydralazine and procainamide, which are not listed here.
* **Option B:** Similarly, this option is incorrect as it lacks specificity and does not correspond with known drugs that cause lupus-like features.
* **Option C:** This option might seem plausible but is incorrect based on the information provided and known associations.

## Clinical Pearl / High-Yield Fact
A key point to remember is that drug-induced lupus erythematosus is often associated with medications like **hydralazine** (used for hypertension) and **procainamide** (used for arrhythmias). A classic clinical pearl is that DILE usually resolves upon withdrawal of the offending drug, which is a distinguishing feature from idiopathic SLE.

## Correct Answer Line
**Correct Answer: D.**